As of 24 August 2023 Emergence Therapeutics is a wholly owned subsidiary of Eli Lilly and Company

Emergence Therapeutics AG
Schifferstrasse 210, 47059 Duisburg, Germany
E-Mail administration [at]

Executive Board (Vorstand): Alexander Horn
Chairman of the Supervisory Board: Philip Johnson

Registered at the commercial court Duisburg under HRB 32381
VAT ID DE327292222

Responsible for the content: Alexander Horn, Emergence Therapeutics AG